Late , late doxorubicin cardiotoxicity .
Cardiac toxicity is a major complication which limits the use of adriamycin as a chemotherapeutic agent .
Cardiomyopathy is frequent when the total dose exceeds 600 mg / m2 and occurs within one to six months after cessation of therapy .
A patient is reported who developed progressive cardiomyopathy two and one - half years after receiving 580 mg / m2 which apparently represents late , late cardiotoxicity .